| 產(chǎn)品編號(hào) | bs-2015R |
| 英文名稱 | S100B Rabbit pAb |
| 中文名稱 | S100B蛋白抗體 |
| 別 名 | NEF; Protein S100 B; Protein S100-B; S 100 calcium binding protein beta chain; S 100 protein beta chain; S 100 protein beta subunit; S-100 protein beta chain; S-100 protein subunit beta; S100; S100 calcium binding protein B; S100 calcium binding protein beta(neural); S100 calcium binding protein beta chain; S100 calcium-binding protein B; S100 protein beta chain; S100B_HUMAN; S100beta. S100 β; S100-β; S100β; |
 |
Specific References (5) | bs-2015R has been referenced in 5 publications.
[IF=15.863] Zhu, Yaqiong. et al. Peripheral nerve defects repaired with autogenous vein grafts filled with platelet-rich plasma and active nerve microtissues and evaluated by novel multimodal ultrasound techniques. Biomaterials Research. 2022 Dec;26(1):1-29 IF ; Rabbit.
[IF=9.965] Wei-Bin Wang. et al. An anisotropic nanobox based core-shell-satellite nanoassembly of multiple SERS enhancement with heterogeneous interface for stroke marker determination. J COLLOID INTERF SCI. 2023 May;:
[IF=7.271] Martin Selinger. et al. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors. COMPUT STRUCT BIOTEC. 2022 Jan;20:2759 IF ; Human.
[IF=5.264] Li et al. Nerve injury-related autoimmunity activation leads to chronic inflammation and chronic neuropathic pain. (2013) Anesthesiolog. 118:416-29 ICC/IF(ICC) ; Rat.
[IF=2.94] Zhang, Shuai-nan, et al. "Cerebral potential biomarkers discovery and metabolic pathways analysis of α-synucleinopathies and the dual effects of Acanthopanax senticosus Harms on central nervous system through metabolomics analysis." Journal of ethnopharmacology (2015). WB ; Mouse.
|
| 研究領(lǐng)域 | 腫瘤 細(xì)胞生物 神經(jīng)生物學(xué) 細(xì)胞周期蛋白 細(xì)胞分化 表觀遺傳學(xué) |
| 抗體來源 | Rabbit |
| 克隆類型 | Polyclonal |
| 克 隆 號(hào) | |
| 交叉反應(yīng) | Human |
| 產(chǎn)品應(yīng)用 | WB=1:500-2000,IHC-P=1:100-500,IHC-F=1:100-500,IF=1:100-500
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理論分子量 | 10 kDa |
| 檢測(cè)分子量 | |
| 細(xì)胞定位 | 細(xì)胞核 細(xì)胞漿 |
| 性 狀 | Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human S100B: 31-92/92 |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 緩 沖 液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| 保存條件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 產(chǎn)品介紹 |
S100 beta is a member of the S100 family of proteins containing 2 EF-hand calcium binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21; however, this gene is located at 21q22.3. This protein may function in neurite extension, proliferation of melanoma cells, stimulation of Ca2+ fluxes, inhibition of PKC mediated phosphorylation, astrocytosis and axonal proliferation, and inhibition of microtubule assembly. Chromosomal rearrangements and altered expression of this gene have been implicated in several neurological, neoplastic, and other types of diseases, including Alzheimer's disease, Down's syndrome, epilepsy, amyotrophic lateral sclerosis, melanoma, and type I diabetes. Function: Weakly binds calcium but binds zinc very tightly-distinct binding sites with different affinities exist for both ions on each monomer. Physiological concentrations of potassium ion antagonize the binding of both divalent cations, especially affecting high-affinity calcium-binding sites. Binds to and initiates the activation of STK38 by releasing autoinhibitory intramolecular interactions within the kinase. Interaction with AGER after myocardial infarction may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling. Subunit: Dimer of either two alpha chains, or two beta chains, or one alpha and one beta chain. The S100B dimer binds two molecules of STK38 (By similarity). The S100B dimer interacts with two molecules of CAPZA1. Subcellular Location: Cytoplasm. Nucleus. Tissue Specificity: Although predominant among the water-soluble brain proteins, S100 is also found in a variety of other tissues. Similarity: Belongs to the S-101 family. Contains 2 EF-hand domains. SWISS: P04271 Gene ID: 6285 Database links: Entrez Gene: 6285 Human Entrez Gene: 20203 Mouse Omim: 176990 Human SwissProt: P04271 Human SwissProt: P50114 Mouse Unigene: 422181 Human Unigene: 235998 Mouse Unigene: 8937 Rat 結(jié)構(gòu)蛋白（Structural Proteins） S100B是一組可溶性、相對(duì)低分子質(zhì)量、高酸性蛋白，屬神經(jīng)膠質(zhì)細(xì)胞特異性蛋白，亦可存在于神經(jīng)纖維中。在研究腸神經(jīng)系統(tǒng)的形態(tài)特征及結(jié)構(gòu)特征中，S100B有良好的表達(dá)功能。 S100B蛋白其生理作用尚不清楚，可能與細(xì)胞內(nèi)鈣離子媒介的調(diào)節(jié)作用有關(guān)。S100B蛋白可存在于神經(jīng)鞘瘤，成軟骨細(xì)胞瘤、軟骨肉瘤、骨肉瘤、神經(jīng)膠質(zhì)瘤、郎格罕斯細(xì)胞瘤、一些癌腫和黑素細(xì)胞腫瘤等。 在免疫組化中，除了惡性黑素瘤皮損，S100B蛋白還在良性黑素細(xì)胞痣中增加，如：藍(lán)痣、普通后天痣、雀斑樣痣、Spitz痣、氣球狀細(xì)胞痣、色素性梭形細(xì)胞痣和發(fā)育不良痣中表達(dá)。還有報(bào)道S100B蛋白的染色強(qiáng)度與腫瘤細(xì)胞的黑素含量呈負(fù)相關(guān)。結(jié)締組織增生性的或親神經(jīng)的黑素瘤不易染色。 |
| 產(chǎn)品圖片 |
Sample:
Lane 1、2: Recombinant human S100B protein, N-His
Primary: Anti- S100B (bs-2015R) at 1/1000 dilution
Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
Predicted band size: 10 kDa
Observed band size: 10 kDa
Paraformaldehyde-fixed, paraffin embedded (human brain glioma); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (S100B) Polyclonal Antibody, Unconjugated (bs-2015R) at 1:200 overnight at 4°C, followed by operating according to SP Kit(Rabbit) (sp-0023) instructionsand DAB staining.
Paraformaldehyde-fixed, paraffin embedded (Human glioblastoma); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (S100B) Polyclonal Antibody, Unconjugated (bs-2015R) at 1:200 overnight at 4°C, followed by operating according to SP Kit(Rabbit) (sp-0023) instructionsand DAB staining.
Paraformaldehyde-fixed, paraffin embedded (human brain ); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (S100B) Polyclonal Antibody, Unconjugated (bs-2015R) at 1:200 overnight at 4°C, followed by operating according to SP Kit(Rabbit) (sp-0023) instructionsand DAB staining.
Paraformaldehyde-fixed, paraffin embedded (human brain glioma); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (S100B) Polyclonal Antibody, Unconjugated (bs-2015R) at 1:200 overnight at 4°C, followed by operating according to SP Kit(Rabbit) (sp-0023) instructionsand DAB staining.
Paraformaldehyde-fixed, paraffin embedded (human brain ); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (S100B) Polyclonal Antibody, Unconjugated (bs-2015R) at 1:200 overnight at 4°C, followed by operating according to SP Kit(Rabbit) (sp-0023) instructionsand DAB staining.
|
